|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/04 | |
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3434673 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16895281.0 |
| Europos patento paraiškos padavimo data | 2016-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2016/111717 |
| Data | 2016-12-23 |
| (87) | Numeris | WO 2017/161937 |
| Data | 2017-09-28 |
| (30) | Numeris | Data | Šalis |
| 201610165018 | 2016-03-22 | CN |
| (72) |
CHEN, Zhongke, CN
LIU, Fuping, CN
LIU, Lei, CN
BAO, Rudi, CN
|
| (73) |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.,
Economic and Technological Development Zone Lianyungang, Jiangsu 222047,
CN
Shanghai Hansoh Biomedical Co., Ltd., Building 2 No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 201203, CN |
| (54) | EGFR INHIBITOR FREE BASE OR ACID SALT POLYCRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND APPLICATION |
| EGFR INHIBITOR FREE BASE OR ACID SALT POLYCRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND APPLICATION |